miR-15, miR-26, miR -31,miR -145, miR-147, miR-188, miR-215, miR-216 miR-331, mmu-miR-292-3p regulated genes and pathways as targets for therapeutic intervention

Details for Australian Patent Application No. 2007299748 (hide)

Owner Asuragen, Inc.

Inventors Patrawala. Lubna; Byrom, Mike; Brown, David; Johnson, Charles D.; Bader, Andreas G.

Agent Pizzeys

Pub. Number AU-A-2007299748

PCT Pub. Number WO2008/036776

Priority 60/826,173 19.09.06 US; 60/948,350 06.07.07 US

Filing date 19 September 2007

Wipo publication date 27 March 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036776 Priority application(s): WO2008/036776

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299764-Method of optimizing the treatment of Philadelphia-positive leukemia with Abl tyrosine kinase inhibitors

2007299738-Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief